Evidence map›Paper›PMID 32397979›Full record

ArticleBMC complementary medicine and therapies2020

Evaluation of neuroprotective and anti-amnesic effects of Elaeagnus umbellata Thunb. On scopolamine-induced memory impairment in mice.

Nausheen Nazir, Muhammad Zahoor, Mohammad Nisar, Nasiara Karim, Abdul Latif, Sajjad Ahmad, Zia Uddin

Abstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Investigating the Anti-Inflammatory Activity ofFoods (Basel, Switzerland) · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Antiangiogenic potential ofOpen medicine (Warsaw, Poland) · 2025
    Article
  7. Antioxidants (Basel, Switzerland) · 2024
    Article
  8. Article
  9. Article
  10. IBRO neuroscience reports · 2023
    Article
  11. Article
  12. Saudi journal of biological sciences · 2023
    Review
  13. Biological Evaluation ofPharmaceuticals (Basel, Switzerland) · 2023
    Article
  14. Article
  15. Article
  16. Molecules (Basel, Switzerland) · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Phytochemical profiling and antioxidant potential ofSaudi journal of biological sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Nausheen NazirDepartment of Biochemistry, University of Malakand, Chakdara Dir (L), Khyber Pakhtunkhwa, Pakistan. nausheen.nazir@uom.edu.pk.ORCID http://orcid.org/0000-0003-4289-3970
Muhammad ZahoorDepartment of Biochemistry, University of Malakand, Chakdara Dir (L), Khyber Pakhtunkhwa, Pakistan.
Mohammad NisarDepartment of Botany, University of Malakand, Chakdara Dir (L), Khyber Pakhtunkhwa, Pakistan.
Nasiara KarimDepartment of Pharmacy, University of Malakand, Chakdara Dir (L), Khyber Pakhtunkhwa, Pakistan.
Abdul LatifDepartment of Chemistry, University of Malakand, Chakdara Dir (L), Khyber Pakhtunkhwa, Pakistan.
Sajjad AhmadDepartment of Pharmacy, Sarhad University of Information Technology, Peshawar, Pakistan.
Zia UddinDepartment of Pharmacy, COMSATS University Islamabad, Abbottabad Campus, Abbottabad, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundElaeagnus umbellata is abundantly found in Himalayan regions of Pakistan which is traditionally used to treat various health disorders. However, the experimental evidence supporting the anti-amnesic effect is limited. Therefore the study was aimed to evaluate the prospective beneficial effect of E. umbellata on learning and memory in mice.

objectivesTo assess neuroprotective and anti-amnesic effects of E. umbellata fruit extracts and isolated compounds on the central nervous system.

methodsMajor phytochemical groups present in methanolic extract of E. umbellata were qualitatively determined. The total phenolic and flavonoid contents were also determined in extract/fractions of E. umbellata. On the basis of in vitro promising anticholinesterases (AChE & BChE) and antioxidant activities observed for CHF. Ext and isolated compound-I (Chlorogenic acid = CGA), they were further evaluated for learning and memory in normal and scopolamine-induced cognitive impairment in mice using memory behavioral tests such as the Y maze and Novel object recognition using standard procedures. The test sample were further assessed for in vivo anticholinesterases (AChE & BChE) and DPPH free radical scavenging activities in mice brain sample and finally validated by molecular docking study using GOLD software.

resultsThe extract/fractions and isolated compounds were tested for their anticholinesterase and antioxidant potentials. The CHF. Ext and CGA showed maximum % inhibition of tested cholinesterases and free radicals. The CHF. Ext and CGA reversed the effects of scopolamine in mice. The CHF. Ext and CGA significantly increased the alternate arm returns and % spontaneous alteration performance while escape latency times (second) significantly decreased in Y maze test. The CHF. Ext and CGA significantly increased the time spent with novel object and also increased the discrimination index in the Novel object recognition test. Furthermore, molecular docking was used to validate the mechanism of cholinesterases inhibition of isolated compounds.

conclusionThe data obtained from behavioral and biochemical studies (AChE/BChE and DPPH/ABTS inhibition) have shown that E. umbellata possessed significant memory enhancing potency. These results suggest that E. umbellata extract possess potential antiamnesic effects and amongst the isolated compounds, compound I could be more effective anti-amnesic therapeutics. However, further studies are needed to identify the exact mechanism of action.

Indexed as

AmnesiaAnimalsAntioxidantsCholinesterase InhibitorsDisease Models, AnimalElaeagnaceaeMiceNeuroprotective AgentsPakistanPlant ExtractsScopolamineAntioxidantsCholinesterase InhibitorsElaeagnus umbellata extractNeuroprotective AgentsPlant ExtractsScopolamineAmnesiaCholinesterasesElaeagnus umbellataMolecular dockingNovel object recognition testScopolamineY-maze test

Identifiers

PMID32397979
PMCPMC7216467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.